These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34752551)

  • 1. Evaluation of Patient Factors Associated With Achieving Goal Hemoglobin A1c in Collaborative Drug Therapy Management Ambulatory Care Clinics by Clinical Pharmacists: A Retrospective Chart Review.
    Torkos S; Burke JM; Zaiken K
    J Pharm Technol; 2021 Feb; 37(1):3-11. PubMed ID: 34752551
    [No Abstract]   [Full Text] [Related]  

  • 2. Barriers interfering with establishment of Collaborative Drug Therapy Management (CDTM) agreements between clinical pharmacists and physicians.
    Alhossan A; Alazba A
    Saudi Pharm J; 2019 Jul; 27(5):713-716. PubMed ID: 31297026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pharmacist-Led Diabetes Management in Primary Care Clinics.
    Pontefract BA; King BS; Gothard DM; King CA
    Innov Pharm; 2018; 9(2):1-8. PubMed ID: 34007692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative drug therapy management and comprehensive medication management-2015.
    ; McBane SE; Dopp AL; Abe A; Benavides S; Chester EA; Dixon DL; Dunn M; Johnson MD; Nigro SJ; Rothrock-Christian T; Schwartz AH; Thrasher K; Walker S
    Pharmacotherapy; 2015 Apr; 35(4):e39-50. PubMed ID: 25884536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Feasibility and Utility of a Pharmacist-Centered Collaborative Drug Therapy Management Program for Oncology-Based Symptom Management.
    Hansen EA; Pietkiewicz JM; Blum BL
    J Pharm Pract; 2016 Jun; 29(3):206-11. PubMed ID: 25510586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes Associated with Pharmacist-Led Diabetes Collaborative Drug Therapy Management in a Medicaid Population.
    Biltaji E; Yoo M; Jennings BT; Leiser JP; McAdam-Marx C
    J Pharm Health Serv Res; 2017 Mar; 8(1):59-62. PubMed ID: 28630653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life.
    Isetts BJ; Schondelmeyer SW; Heaton AH; Wadd WB; Hardie NA; Artz MB
    Res Social Adm Pharm; 2006 Mar; 2(1):129-42. PubMed ID: 17138505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pharmacist-Led Clinics on Health Outcomes of Patients With Diabetes at a Ministry of Health Diabetes & Endocrinology Center, Saudi Arabia: A Retrospective Study.
    Alqifari SF; AlMharwal B; Aldawish R; Almokhlef SA
    Cureus; 2022 Jun; 14(6):e25923. PubMed ID: 35844320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in clinical markers observed from pharmacist-managed cardiovascular risk reduction clinics in federally qualified health centers: A retrospective cohort study.
    Gonzalvo JD; Meredith AH; Pastakia SD; Peters M; Eberle M; Schmelz AN; Pence L; Triboletti JS; Walroth TA
    PLoS One; 2023; 18(3):e0282940. PubMed ID: 36920963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of pharmacist collaborative drug therapy management in hospitals.
    Thomas J; Bharmal M; Lin SW; Punekar Y
    Am J Health Syst Pharm; 2006 Dec; 63(24):2489-99. PubMed ID: 17158697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.
    Machado M; Bajcar J; Guzzo GC; Einarson TR
    Ann Pharmacother; 2007 Oct; 41(10):1569-82. PubMed ID: 17712043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic.
    Erwin PB; Pitlick MK; Peters GL
    Diabetes Spectr; 2015 Nov; 28(4):237-44. PubMed ID: 26600724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey Evaluating the Practice of Children's Hospitals Having Pharmacist Collaborative Drug Therapy Management Protocols.
    Welsh C; Miah R; Girotto J
    J Pediatr Pharmacol Ther; 2016; 21(6):494-501. PubMed ID: 28018151
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaboration with pharmacy services in a family practice for the medically underserved.
    Enfinger F; Campbell K; Taylor RJ
    Pharm Pract (Granada); 2009 Oct; 7(4):248-53. PubMed ID: 25136401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Collaborative Drug Therapy Management and Clinical Pharmacy Services in an Outpatient Psychiatric Clinic.
    Tewksbury A; Bozymski KM; Ruekert L; Lum C; Cunningham E; Covington F
    J Pharm Pract; 2018 Jun; 31(3):272-278. PubMed ID: 28539104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes.
    Edwards KL; Hadley RL; Baby N; Yeary JC; Chastain LM; Brown CD
    J Pharm Pract; 2017 Aug; 30(4):412-418. PubMed ID: 27568478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management.
    Homan MJ; Reid JH; Nachar VR; Benitez LL; Brown AM; Kraft S; Hough S; Christen C; Frame D; McDevitt RL
    Support Care Cancer; 2021 Nov; 29(11):6505-6510. PubMed ID: 33905012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.